Latest Period
Q4 2025
Security Snapshot
Xtant Medical Holdings, Inc. - Common Stock (XTNT) Institutional Ownership
CUSIP: 98420P308
13F Institutional Holders and Ownership History from Q1 2018 to Q1 2026
Institutions Reporting
35
Shares (Excl. Options)
81,404,745
Price
$0.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- XTNT on NYSE
- Shares outstanding
- 140,036,400
- Price per share
- $0.56
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 81,404,745
- Total reported value
- $63,818,481
- % of total 13F portfolios
- 0%
- Share change
- +957,092
- Value change
- +$760,014
- Number of holders
- 35
- Price from insider filings
- $0.56
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- XTNT - Xtant Medical Holdings, Inc. - Common Stock is tracked under CUSIP 98420P308.
- 35 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 35 to 5 between Q4 2025 and Q1 2026.
- Reported value moved from $63,818,481 to $120,789.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 35 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 98420P308:
Significant Owners of Xtant Medical Holdings, Inc. - Common Stock (XTNT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 49% | 0% | $50,543,166 | 68,394,000 | 0% | Nantahala Capital Management, LLC | 01 Aug 2025 | |
| LYTTON LAURENCE W | 5.5% | -19% | $5,545,441 | -$1,268,237 | 7,702,002 | -19% | LYTTON LAURENCE W | 31 Dec 2025 |
As of 31 Dec 2025, 35 institutional investors reported holding 81,404,745 shares of Xtant Medical Holdings, Inc. - Common Stock (XTNT). This represents 58% of the company’s total 140,036,400 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 49% | 68,394,000 | 0% | 3.2% | $53,620,896 |
| AWM Investment Company, Inc. | 4.7% | 6,594,121 | 0% | 0.5% | $5,169,791 |
| VANGUARD GROUP INC | 1.6% | 2,272,591 | -3.5% | 0% | $1,781,712 |
| RENAISSANCE TECHNOLOGIES LLC | 0.66% | 919,860 | +29% | 0% | $721,170 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.35% | 491,949 | 0% | 0% | $385,788 |
| Crescent Grove Advisors, LLC | 0.29% | 412,024 | 0% | 0.03% | $323,027 |
| Hillsdale Investment Management Inc. | 0.26% | 362,200 | 0.01% | $283,965 | |
| CITADEL ADVISORS LLC | 0.21% | 287,798 | +259% | 0% | $225,634 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 0.2% | 280,000 | 0% | 0.19% | $219,520 |
| ACADIAN ASSET MANAGEMENT LLC | 0.14% | 194,062 | 0% | $149,000 | |
| MILLENNIUM MANAGEMENT LLC | 0.14% | 190,846 | -21% | 0% | $149,623 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.12% | 164,100 | 0% | 0% | $128,654 |
| BlackRock, Inc. | 0.08% | 115,782 | -3.8% | 0% | $90,773 |
| Mink Brook Asset Management LLC | 0.08% | 109,466 | 0% | 0.05% | $85,821 |
| WIREGRASS INVESTMENT MANAGEMENT LLC | 0.07% | 103,000 | 0% | 0.07% | $80,752 |
| Tradition Wealth Management, LLC | 0.07% | 100,297 | 0.01% | $78,633 | |
| Private Advisor Group, LLC | 0.06% | 85,000 | -31% | 0% | $66,640 |
| TWO SIGMA SECURITIES, LLC | 0.06% | 77,350 | 0.01% | $60,642 | |
| NORTHERN TRUST CORP | 0.04% | 57,464 | -2% | 0% | $45,052 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.03% | 36,158 | 0% | $28,348 | |
| STATE STREET CORP | 0.02% | 31,266 | 0% | 0% | $24,513 |
| PRUDENTIAL FINANCIAL INC | 0.02% | 23,400 | 0% | 0% | $18,346 |
| LAZARD ASSET MANAGEMENT LLC | 0.02% | 22,720 | 0% | $17,812 | |
| Virtu Financial LLC | 0.01% | 20,146 | -36% | 0% | $16,000 |
| Kestra Advisory Services, LLC | 0.01% | 20,000 | 0% | $15,680 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 216,468 | $120,789 | $0.56 | 5 | |
| 2025 Q4 | 81,404,745 | $63,818,481 | +$760,014 | $0.78 | 35 |
| 2025 Q3 | 80,064,653 | $51,958,020 | +$59,666 | $0.65 | 29 |
| 2025 Q2 | 79,963,210 | $59,092,411 | +$9,527,080 | $0.74 | 29 |
| 2025 Q1 | 96,332,001 | $45,274,819 | -$166,227 | $0.47 | 26 |
| 2024 Q4 | 96,692,530 | $42,834,946 | -$1,064,038 | $0.44 | 28 |
| 2024 Q3 | 98,215,048 | $66,126,833 | +$5,325,340 | $0.68 | 27 |
| 2024 Q2 | 90,066,890 | $56,742,224 | -$435,632 | $0.63 | 26 |
| 2024 Q1 | 90,374,385 | $105,738,087 | +$205,479 | $1.17 | 33 |
| 2023 Q4 | 90,202,353 | $101,928,562 | -$82,302 | $1.13 | 31 |
| 2023 Q3 | 90,276,097 | $99,304,130 | +$9,366,353 | $1.10 | 28 |
| 2023 Q2 | 81,765,290 | $76,033,381 | -$53,515 | $0.93 | 19 |
| 2023 Q1 | 81,854,114 | $52,181,371 | -$34,628 | $0.64 | 21 |
| 2022 Q4 | 81,903,507 | $54,055,554 | +$144,724 | $0.66 | 19 |
| 2022 Q3 | 81,682,735 | $58,794,209 | +$779,674 | $0.72 | 12 |
| 2022 Q2 | 80,613,065 | $41,878,151 | +$4,656 | $0.52 | 12 |
| 2022 Q1 | 80,534,844 | $54,787,198 | -$46,947 | $0.68 | 15 |
| 2021 Q4 | 80,663,007 | $45,172,000 | +$87,373 | $0.56 | 17 |
| 2021 Q3 | 80,508,571 | $89,363,000 | -$2,471,600 | $1.11 | 12 |
| 2021 Q2 | 82,710,575 | $134,818,000 | +$13,336,837 | $1.63 | 14 |
| 2021 Q1 | 74,502,096 | $175,824,000 | +$1,768,228 | $2.36 | 14 |
| 2020 Q4 | 73,761,114 | $88,226,000 | +$76,215,399 | $1.20 | 11 |
| 2020 Q3 | 10,131,401 | $8,345,000 | -$186,747 | $0.82 | 12 |
| 2020 Q2 | 10,345,548 | $9,310,000 | -$902,433 | $0.90 | 10 |
| 2020 Q1 | 11,672,319 | $7,820,000 | +$9,453 | $0.67 | 11 |
| 2019 Q4 | 11,656,858 | $18,653,000 | -$32,980 | $1.60 | 9 |
| 2019 Q3 | 11,675,943 | $33,159,000 | -$11,600 | $2.84 | 12 |
| 2019 Q2 | 11,679,733 | $35,039,000 | +$50,902 | $3.00 | 10 |
| 2019 Q1 | 11,662,801 | $35,571,000 | -$210,500 | $3.05 | 9 |
| 2018 Q4 | 11,735,030 | $18,894,000 | +$69,173 | $1.61 | 11 |
| 2018 Q3 | 11,691,562 | $45,015,000 | +$2,792,758 | $3.85 | 11 |
| 2018 Q2 | 10,963,855 | $60,850,000 | +$2,123,813 | $5.55 | 12 |
| 2018 Q1 | 10,569,679 | $83,108,926 | +$83,108,926 | $7.89 | 11 |